Management of antithrombotic agents for endoscopic procedures.

GUIDELINE TITLE
Management of antithrombotic agents for endoscopic procedures.

BIBLIOGRAPHIC SOURCE(S)
ASGE Standards of Practice Committee, Anderson MA, Ben-Menachem T, Gan SI, Appalaneni V, Banerjee S, Cash BD, Fisher L, Harrison ME, Fanelli RD, Fukami N, Ikenberry SO, Jain R, Khan K, Krinsky ML, Lichtenstein DR, Maple JT, Shen B, Strohmeyer L, Baron T, Dominitz JA. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009 Dec;70(6):1060-70. [79 references] PubMed

GUIDELINE STATUS
This is the current release of the guideline.

This guideline updates previously published versions: Zuckerman MJ, Hirota WK, Adler DG, Davila RE, Jacobson BC, Leighton JA, Qureshi WA, Rajan E, Hambrick RD, Fanelli RD, Baron TH, Faigel DO. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc 2005 Feb;61(2):189-94. [56 references] PubMed

Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, Mallery JS, Raddawi HM, Vargo JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002 Jun;55(7):775-9. [29 references]

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

March 12, 2010 - Plavix (clopidogrel): The U.S. Food and Drug Administration (FDA) notified healthcare professionals and patients that a Boxed Warning has been added to the prescribing information for Plavix, an anti–blood clotting medication. The Boxed Warning includes information about reduced effectiveness in patients who are poor metabolizers of Plavix.
November 17, 2009 - Plavix (clopidogrel): The FDA notified healthcare professionals of new safety information concerning an interaction between clopidogrel (Plavix) and omeprazole (Prilosec/Prilosec OTC) used to reduce stomach acid. New data show that when clopidogrel and omeprazole are taken together, the effectiveness of clopidogrel is reduced.

open here to see the full-text:
Management of antithrombotic agents for endoscopic procedures.